Heart surgeons see innovations with tiny new pumps

Sun_StarTribune

Star Tribune photo

[Star Tribune, November 10, 2013] A new generation of cardiac devices scheduled for human trials in Europe and the United States next year has heart surgeons talking about a possible sea change in the treatment of patients suffering from the most severe level of heart failure, which affects 150,000 to 200,000 Americans a year and kills thousands.

Dr. Ben Sun is a cardiac and thoracic surgeon for the Minneapolis Heart Institute at Abbott Northwestern Hospital and a research physician for the Minneapolis Heart Institute Foundation with a background in molecular biophysics and biochemistry. He describes himself as an “old man” in the realm of heart pumps.

Read the entire story here.

Get Allina in the News delivered to your email inbox each morning.